CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 30,000 shares at $2.82 ($84,600)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 900 shares at $3.28 ($2,952)
- 4 Open-market buy Chief Medical Officer bought 2,250 shares at $3.25 ($7,313)
- 4 Exercise or conversion Director acquired 60,000 shares (option exercise)
- 4 Open-market buy Chief Medical Officer bought 6,000 shares at $3.00 ($18,000)
- 4 Open-market buy Director bought 20,000 shares at $3.10 ($62,000)
- 4 Open-market buy Chief Financial Officer bought 6,500 shares at $3.00 ($19,500)
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Chief Financial Officer bought 18,800 shares at $3.36 ($63,168)
- 4 Open-market buy Chief Financial Officer bought 2,850 shares at an average $3.46 ($9,875)
- 4 Open-market buy Chief Executive Officer bought 400 shares at $3.66 ($1,464)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $3.98 ($3,980)
- 4 Open-market buy Chief Financial Officer bought 1,700 shares at an average $3.98 ($6,764)
- 4 Open-market buy Chief Medical Officer bought 3,300 shares at $3.00 ($9,900)
- 4 Open-market buy Director bought 5,000 shares at $3.00 ($15,000)
- 4 Open-market buy Chief Executive Officer bought 500 shares at $3.30 ($1,650)
- 4 Open-market buy Director bought 1,300 shares at $3.05 ($3,965)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at an average $3.20 ($6,400)
Page 16 of 17 · 340 filings